Internal Medicine, Interventional Cardiology · Oklahoma City, OK
NPI
1215062799
Since 2007
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
5224 E I 240 Service Rd Ste 100
Oklahoma City, OK, 73135
Phone (405) 608-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
4,194 services
Medicare patients, 2024
1,000
Average age 75
Drug cost, 2024
$1.3M
11,452 prescriptions
Company payments, 2025
$386
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nabhan Alnabhan was code 99214 (office e&m - established), 897 times for 424 patients. In total Nabhan Alnabhan billed 4,194 services in 110 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 897 | 424 | $64.93 | $58K |
| 93010 Electrocardiogram | Facility | 665 | 515 | $5.49 | $3,654 |
| 99214 Office E&M - Established | Office | 279 | 157 | $64.02 | $18K |
| 93306 Echocardiography (TTE/TEE) | Facility | 171 | 165 | $45.13 | $7,718 |
| 93306 Echocardiography (TTE/TEE) | Office | 143 | 141 | $55.52 | $7,939 |
| 93018 Electrocardiogram | Office | 118 | 112 | $9.63 | $1,137 |
| 93010 Electrocardiogram | Office | 112 | 99 | $5.20 | $582 |
| 99152 Anesthesia | Facility | 109 | 89 | $8.79 | $959 |
| 99215 Office E&M - Established | Facility | 93 | 67 | $95.66 | $8,897 |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 90 | 89 | $26.12 | $2,351 |
| 78452 Myocardial Perfusion Scan | Office | 83 | 82 | $51.12 | $4,243 |
| 93018 Electrocardiogram | Facility | 83 | 81 | $10.10 | $838 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 75 | 74 | $35.65 | $2,674 |
| 93458 Percutaneous Transcatheterization | Facility | 68 | 66 | $185.36 | $13K |
| 78452 Myocardial Perfusion Scan | Facility | 67 | 67 | $55.26 | $3,702 |
By year: 2022 $210K for 4,285 services; 2023 $205K for 4,499 services; 2024 $202K for 4,194 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 51 | 44 | $10.35 | $528 |
| 80048 Clinical Chemistry | 38 | 29 | $8.29 | $315 |
| 80061 Clinical Chemistry | 36 | 34 | $13.12 | $472 |
| 85025 Blood Count | 15 | 14 | $7.61 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Nabhan Alnabhan prescribed most often to Medicare patients was Spironolactone, with 994 prescriptions and refills. In total Nabhan Alnabhan wrote 11,452 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 994 | 1,789 | 211 | $7,757 |
| Rosuvastatin Calcium Generic | 964 | 1,830 | 197 | $40K |
| Clopidogrel Clopidogrel Bisulfate | 827 | 1,712 | 183 | $26K |
| Metoprolol Succinate Generic | 718 | 1,502 | 178 | $8,901 |
| Lisinopril Generic | 623 | 1,224 | 135 | $3,720 |
| Carvedilol Generic | 510 | 933 | 108 | $11K |
| Eliquis Apixaban | 483 | 728 | 100 | $419K |
| Amlodipine Besylate Generic | 477 | 915 | 121 | $5,207 |
| Atorvastatin Calcium Generic | 436 | 973 | 117 | $9,868 |
| Losartan Potassium Generic | 404 | 806 | 105 | $4,553 |
| Potassium Chloride Generic | 358 | 645 | 91 | $4,504 |
| Telmisartan Generic | 336 | 588 | 72 | $14K |
| Furosemide Generic | 330 | 577 | 82 | $1,475 |
| Hydrochlorothiazide Generic | 275 | 506 | 64 | $1,111 |
| Jardiance Empagliflozin | 220 | 288 | 41 | $160K |
Brand drugs: 1,588 claims; generic drugs: 9,864 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nabhan Alnabhan $386 ($386 in general payments such as food, travel and fees) from 5 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.